RWA
SCMP

Ropes Wealth Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Ropes Wealth Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-133
Closed -$2K – 826
2017
Q4 		$2K Hold
133
– – ﹤0.01% 750
2017
Q3 		$2K Buy
+133
New +$1.49K ﹤0.01% 684

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Ropes Wealth Advisors's SCMP Position: Q1 2018 in Review

Ropes Wealth Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 133 shares — an estimated $2K sold.

Ropes Wealth Advisors first reported a position in SCMP in Q3 2017 and held it in 2 quarters. The position peaked at $2K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Ropes Wealth Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Ropes Wealth Advisors sold 133 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2K.
  • Ropes Wealth Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
  • Ropes Wealth Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $2K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Ropes Wealth Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.